Heterologous prime/boost immunization of rhesus monkeys by using diverse poxvirus vectors
about
Poxvirus vectors as HIV/AIDS vaccines in humansHeterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical TrialsProtective effect of Toll-like receptor 4 in pulmonary vaccinia infectionRecombinant vector-induced HIV/SIV-specific CD4+ T lymphocyte responses in rhesus monkeys.Vaccination reduces simian-human immunodeficiency virus sequence reversion through enhanced viral controlA phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjectsPoxvirus-based vaccine therapy for patients with advanced pancreatic cancer.Replicating and non-replicating viral vectors for vaccine developmentImpact of anti-orthopoxvirus neutralizing antibodies induced by a heterologous prime-boost HIV-1 vaccine on insert-specific immune responsesMultilineage polyclonal engraftment of Cal-1 gene-modified cells and in vivo selection after SHIV infection in a nonhuman primate model of AIDSMagnitude and quality of vaccine-elicited T-cell responses in the control of immunodeficiency virus replication in rhesus monkeysUse of mchI encoding immunity to the antimicrobial peptide microcin H47 as a plasmid selection marker in attenuated bacterial live vectors.Enhancing poxvirus vectors vaccine immunogenicity.Immunogenicity of recombinant Modified Vaccinia Ankara following a single or multi-dose vaccine regimen in rhesus monkeys.Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimenPrime-boost vaccination with recombinant mumps virus and recombinant vesicular stomatitis virus vectors elicits an enhanced human immunodeficiency virus type 1 Gag-specific cellular immune response in rhesus macaques.VSV-GP: a potent viral vaccine vector that boosts the immune response upon repeated applications.Clinical applications of attenuated MVA poxvirus strain.Heterologous prime-boost-boost immunisation of Chinese cynomolgus macaques using DNA and recombinant poxvirus vectors expressing HIV-1 virus-like particles.Vector order determines protection against pathogenic simian immunodeficiency virus infection in a triple component vaccine by balancing CD4+ and CD8+ T-cell responses.Differential CD4+ versus CD8+ T-cell responses elicited by different poxvirus-based human immunodeficiency virus type 1 vaccine candidates provide comparable efficacies in primates.Prime-boost vaccinations using recombinant flavivirus replicon and vaccinia virus vaccines: an ELISPOT analysis.Partial protection against SIV challenge by vaccination of adenovirus and MVA vectors in rhesus monkeys.Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPVPOS Cancers.Replicating adenovirus vector prime/protein boost strategies for HIV vaccine development
P2860
Q26995078-DFF64978-8A64-4349-9EA0-39AF5A674327Q28394899-B2383F94-7179-459D-976D-81BC4E552265Q33370547-4F19B34F-0942-4C3E-A740-04E0AEEA9285Q34189785-CD073E30-5323-44D5-AE9D-4A0C0FADFC47Q34416586-8738DEEE-7CAC-43DA-B763-EE9FF5794363Q34593969-9CD7C511-3617-4335-B7A7-DE5EDCAB7305Q36412657-5C2603BE-4942-4E33-942C-314CC096204AQ36464587-C64674F6-4735-482C-AF6B-B14ECF395F05Q36593175-7D2D7142-3B4F-481F-8B0E-28DFC0C62ABBQ36613666-B3A6F099-DA10-4D08-B39F-0D7405D2B786Q36845836-1DB9081C-579E-4DAB-92DB-EE6700E00721Q36898558-653F68C1-FD0A-4D8B-B52C-2F2E31A163D9Q36978452-A8CF53EE-CD1A-437E-AEAD-535B9467CBE0Q37174356-FB9976CB-6CEF-4311-A95E-3CF33801FF84Q37242521-FF83B5D3-FFC8-4982-B32D-54EA540099E7Q37355979-79E677FB-29B5-4AC0-BC79-0981CD2CC9EFQ37714030-942123B3-47F6-4A9A-8706-20431B427069Q38156198-3760968F-5AD0-459E-AFEA-1C6A6F02EE92Q38541824-4144A914-649D-4054-BA40-724CCB5FC8CAQ40042419-DEABC9BE-D6E7-4352-BF5F-D85112ECA0D8Q42100401-61E860CE-497C-4416-B2CB-6E63E18336DDQ42998966-5250837E-AD4D-4035-A942-12A9A134D0BEQ45888470-189CACD4-0792-4209-BF44-F228F73E88DFQ55652233-595AC0F7-C7B8-43D8-81B2-BD46B76BE7ACQ56993265-4F14B69E-9001-4651-AE45-66D87D63E06D
P2860
Heterologous prime/boost immunization of rhesus monkeys by using diverse poxvirus vectors
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Heterologous prime/boost immunization of rhesus monkeys by using diverse poxvirus vectors
@ast
Heterologous prime/boost immunization of rhesus monkeys by using diverse poxvirus vectors
@en
type
label
Heterologous prime/boost immunization of rhesus monkeys by using diverse poxvirus vectors
@ast
Heterologous prime/boost immunization of rhesus monkeys by using diverse poxvirus vectors
@en
prefLabel
Heterologous prime/boost immunization of rhesus monkeys by using diverse poxvirus vectors
@ast
Heterologous prime/boost immunization of rhesus monkeys by using diverse poxvirus vectors
@en
P2093
P2860
P356
P1433
P1476
Heterologous prime/boost immunization of rhesus monkeys by using diverse poxvirus vectors
@en
P2093
Alicia Gomez-Yafal
Dennis Panicali
Gail Mazzara
Jenny G Parvani
Kelledy Manson
Michael S Wyand
Norman L Letvin
Phillip D Markham
Sampa Santra
Valerie Philippon
P2860
P304
P356
10.1128/JVI.00744-07
P407
P577
2007-06-06T00:00:00Z